In diet-induced obesity (DIO) mouse mode, FGF21 treatment inhibited the expression of hepatic sterol regulatory element-binding protein-1 (SREBP-1) gene and a wide array of genes involved in fatty acid and triglyceride synthesis, which was associated with the significant reduction in hepatic triglyceride levels [17]. Here, SREBF1 is linked to obesity disorder.